BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 12522088)

  • 1. Butyrylcholinesterase and acetylcholinesterase activity and quantal transmitter release at normal and acetylcholinesterase knockout mouse neuromuscular junctions.
    Minic J; Chatonnet A; Krejci E; Molgó J
    Br J Pharmacol; 2003 Jan; 138(1):177-87. PubMed ID: 12522088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Butyrylcholinesterase and the control of synaptic responses in acetylcholinesterase knockout mice.
    Girard E; Bernard V; Minic J; Chatonnet A; Krejci E; Molgó J
    Life Sci; 2007 May; 80(24-25):2380-5. PubMed ID: 17467011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synaptic remodeling at the skeletal neuromuscular junction of acetylcholinesterase knockout mice and its physiological relevance.
    Girard E; Barbier J; Chatonnet A; Krejci E; Molgó J
    Chem Biol Interact; 2005 Dec; 157-158():87-96. PubMed ID: 16274683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of acetylcholine release by muscarinic receptors at the mouse neuromuscular junction depends on the activity of acetylcholinesterase.
    Minic J; Molgó J; Karlsson E; Krejci E
    Eur J Neurosci; 2002 Feb; 15(3):439-48. PubMed ID: 11876771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of acetylcholinesterase and butyrylcholinesterase inhibition on breathing in mice adapted or not to reduced acetylcholinesterase.
    Boudinot E; Taysse L; Daulon S; Chatonnet A; Champagnat J; Foutz AS
    Pharmacol Biochem Behav; 2005 Jan; 80(1):53-61. PubMed ID: 15652380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abundant tissue butyrylcholinesterase and its possible function in the acetylcholinesterase knockout mouse.
    Li B; Stribley JA; Ticu A; Xie W; Schopfer LM; Hammond P; Brimijoin S; Hinrichs SH; Lockridge O
    J Neurochem; 2000 Sep; 75(3):1320-31. PubMed ID: 10936216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced acetylcholine receptor density, morphological remodeling, and butyrylcholinesterase activity can sustain muscle function in acetylcholinesterase knockout mice.
    Adler M; Manley HA; Purcell AL; Deshpande SS; Hamilton TA; Kan RK; Oyler G; Lockridge O; Duysen EG; Sheridan RE
    Muscle Nerve; 2004 Sep; 30(3):317-27. PubMed ID: 15318343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitivity of butyrylcholinesterase knockout mice to (--)-huperzine A and donepezil suggests humans with butyrylcholinesterase deficiency may not tolerate these Alzheimer's disease drugs and indicates butyrylcholinesterase function in neurotransmission.
    Duysen EG; Li B; Darvesh S; Lockridge O
    Toxicology; 2007 Apr; 233(1-3):60-9. PubMed ID: 17194517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholinergic activation of the murine trachealis muscle via non-vesicular acetylcholine release involving low-affinity choline transporters.
    Nassenstein C; Wiegand S; Lips KS; Li G; Klein J; Kummer W
    Int Immunopharmacol; 2015 Nov; 29(1):173-80. PubMed ID: 26278668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localization of butyrylcholinesterase at the neuromuscular junction of normal and acetylcholinesterase knockout mice.
    Blondet B; Carpentier G; Ferry A; Chatonnet A; Courty J
    J Histochem Cytochem; 2010 Dec; 58(12):1075-82. PubMed ID: 20805581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Respiratory survival mechanisms in acetylcholinesterase knockout mouse.
    Chatonnet F; Boudinot E; Chatonnet A; Taysse L; Daulon S; Champagnat J; Foutz AS
    Eur J Neurosci; 2003 Sep; 18(6):1419-27. PubMed ID: 14511322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mefloquine inhibits cholinesterases at the mouse neuromuscular junction.
    McArdle JJ; Sellin LC; Coakley KM; Potian JG; Quinones-Lopez MC; Rosenfeld CA; Sultatos LG; Hognason K
    Neuropharmacology; 2005 Dec; 49(8):1132-9. PubMed ID: 16081111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance to D-tubocurarine of the rat diaphragm as compared to a limb muscle: influence of quantal transmitter release and nicotinic acetylcholine receptors.
    Nguyen-Huu T; Molgó J; Servent D; Duvaldestin P
    Anesthesiology; 2009 May; 110(5):1011-5. PubMed ID: 19352164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Excessive hippocampal acetylcholine levels in acetylcholinesterase-deficient mice are moderated by butyrylcholinesterase activity.
    Hartmann J; Kiewert C; Duysen EG; Lockridge O; Greig NH; Klein J
    J Neurochem; 2007 Mar; 100(5):1421-9. PubMed ID: 17212694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Butyrylcholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase, are present in human plasma.
    Li B; Sedlacek M; Manoharan I; Boopathy R; Duysen EG; Masson P; Lockridge O
    Biochem Pharmacol; 2005 Nov; 70(11):1673-84. PubMed ID: 16213467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Schwann cells sense and control acetylcholine spillover at the neuromuscular junction by α7 nicotinic receptors and butyrylcholinesterase.
    Petrov KA; Girard E; Nikitashina AD; Colasante C; Bernard V; Nurullin L; Leroy J; Samigullin D; Colak O; Nikolsky E; Plaud B; Krejci E
    J Neurosci; 2014 Sep; 34(36):11870-83. PubMed ID: 25186736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amino acid residues involved in stereoselective inhibition of cholinesterases with bambuterol.
    Bosak A; Gazić I; Vinković V; Kovarik Z
    Arch Biochem Biophys; 2008 Mar; 471(1):72-6. PubMed ID: 18167304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new myasthenic syndrome with end-plate acetylcholinesterase deficiency, small nerve terminals, and reduced acetylcholine release.
    Engel AG; Lambert EH; Gomez MR
    Ann Neurol; 1977 Apr; 1(4):315-30. PubMed ID: 214017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholinesterase activity in human pulmonary arteries and veins.
    Walch L; Taisne C; Gascard JP; Nashashibi N; Brink C; Norel X
    Br J Pharmacol; 1997 Jul; 121(5):986-90. PubMed ID: 9222557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycolytic type I white muscle fibres lack butyrylcholinesterase activity at acetylcholinergic end plates.
    Khan MA
    Cytobios; 1979; 26(103-104):167-73. PubMed ID: 552306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.